CREB1 and neoplasm: Tumor progression of subcutaneously implanted xenografts stably expressing shRNA targeting either CREB or HIF-1 was diminished as determined by both non-invasive luciferase-based imaging and measurements of the excised tumors (Figure 5 and Figure 6).